Sign in

CIK 0001636282

  • Large accelerated filer

Spyre Therapeutics, Inc.

Sign in to watch
Ticker
SYRE
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
464312787
Phone
+1 617-651-5940
Business address
221 CRESCENT STREET, BUILDING 23, SUITE 105, WALTHAM, MA, 02453
Former names
Aeglea BioTherapeutics, Inc.
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$12,349,597
in 6 filings, $12.3M under 10b5-1 plans

Net −$12,349,597. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2018-08-13 GEORGIOU GEORGE Director Exercise or conversion +17,333 $7.28 $126K 155,861
2018-08-13 GEORGIOU GEORGE Director Exercise or conversion +20,000 $4.73 $95K 175,861
2018-08-13 GEORGIOU GEORGE Director Exercise or conversion · Director Stock Option (right to buy) −17,333 6,667
2018-08-13 GEORGIOU GEORGE Director Exercise or conversion · Director Stock Option (right to buy) −20,000 10,000
2018-06-07 GEORGIOU GEORGE Director Grant or award · Director Stock Option (right to buy) +18,400 18,400
2017-12-01 GEORGIOU GEORGE Director Grant or award · Director Stock Option (right to buy) +30,000 30,000
2016-05-17 GEORGIOU GEORGE Director Grant or award · Director Stock Option (right to buy) +24,000 24,000

Page 1 of 1 · 7 trades